Synergy CHC (SNYR) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Operates in consumer health care, beauty, and lifestyle products, with two main brands: FOCUSfactor (brain health supplement) and Flat Tummy (wellness and nutrition for women).
Products are distributed through major retailers (Costco, Amazon, Walmart, CVS, etc.) and direct-to-consumer channels, with international expansion into Canada and the UK.
Growth strategy includes expanding product SKUs, international markets, and leveraging digital engagement (apps, social media).
Asset-light model using contract manufacturing for scalability and flexibility.
Financial performance and metrics
Net revenue for 2024 was $34.8 million, down 19% from $42.8 million in 2023.
For the nine months ended September 30, 2025, net revenue was $24.3 million, a 1% decrease year-over-year.
FOCUSfactor accounted for 86% of net revenue in the first nine months of 2025; Flat Tummy was 14%.
Revenue from a license agreement in foreign markets was $2.9 million in the first nine months of 2025.
Use of proceeds and capital allocation
Proceeds will be used for research and development, working capital, general corporate purposes, potential acquisitions, and debt reduction.
Management retains broad discretion over allocation of net proceeds.
Latest events from Synergy CHC
- Q3 sales fell on rebranding, but profitability, liquidity, and growth plans remain strong.SNYR
Q3 202411 Jan 2026 - All director nominees and key proposals were approved, with results to be filed with the SEC.SNYR
AGM 20256 Jan 2026 - Profitability maintained amid revenue decline; IPO and new launches set stage for 2025 growth.SNYR
Q4 202426 Dec 2025 - Annual meeting to vote on directors, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Stockholders to vote on director elections, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor, equity plan expansion, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Health and wellness firm targets Nasdaq IPO to fund growth amid strong 2023 results and high debt.SNYR
Registration Filing30 Nov 2025 - Consumer health company targets Nasdaq IPO to fund growth amid high debt and concentrated sales.SNYR
Registration Filing30 Nov 2025 - IPO aims to fund brand growth and expansion amid recent financial improvement and high leverage.SNYR
Registration Filing30 Nov 2025